Powered by Google TranslateTranslate

Research & Development

Research & Development

Our R&D activities include research on new products and drug delivery platforms such as controlled drug delivery, multiple-unit pellets system, multi-layer tablet technology, gastro-retentive drug, and hot-melt extrusion delivery.

The Inception of a Product

R&D Overview

Unison Pharmaceuticals has developed globally relevant dossiers and filed with partners across Emerging and Regulated Markets. Further, through our technology platforms which are developed in-house.

A Multi-Disciplinary Approach

Organization & Roles

Fundamental roles that define and structure our state-of-art Research & Development
facilities and enables us to consistently offer our OSD Capabilities.

Formulation & Analytical
Development

Formulation and analytical development teams are able to develop products through QBbD approach.

Intellectual
Property

Our Intellectual Property Team ensures that our platform technologies are covered by legitimate patents.

Technology
Transfer

Our highly skilled scale-up team transfers the products to our production facility.

Project
Management

Our Project Management Team coordinates with all stakeholders, be it internal or external, to function seamlessly and adhere to product timelines.

Regulatory
Assistance

The Regulatory Team is able to file dossiers across the regions. However, Innovations need to transcend into reality.

A Multi-Disciplinary Approach

Dosage Forms

Our technology strengths cover the following drug delivery dosage forms

Immediate Release Tablet

Modified Release Tablet

Multiple Unit Particulate System

Capsule

Formulation R&D Capabilities

High Sheer Mixer

Fluid Bed Drier

Fluid Bed Processor

Bilayer Tablet Compression Machine

Auto Coater

Roll Compactor

Compression of Pellets (MUPS Tablet)

Blister Packing Machine with Alu-Alu Facility

Lab/pilot scale studies

Process optimization/validation studies

Design and development of new dosage forms

Stability studies as per ICH guidance

Technology transfer of new products

Technology and latest development up gradation to provide technically superior, process efficient and International standards products

Regulatory Affairs

Clinical Affairs

Regulatory Affairs

Our Regulatory Affairs team delivers end-to-end solutions across global markets—from dossier strategy through authoring, publishing, approval, and lifecycle maintenance. We specialize in diverse regulatory filings includ... read more

Intellectual Property Rights

With the beginning of International market business, Unison Pharma has started focusing on niche & proprietary 505(b)(2) product development with IP filing program. Currently, Unison IP program activities going on in more than 20 countries worldwide (key major countries US, & Europe). Unison has successfully obtained granted IP rights for its proprietary product protection in majority of countries .

Original text
Rate this translation
Your feedback will be used to help improve Google Translate